article thumbnail

Minimal SARS-CoV-2 diversity suggests a global vaccine is feasible

Scienmag

Genetic analysis of sequences from more than 27,000 individuals infected with the coronavirus that causes COVID-19 reveals that the virus has mutated minimally since December 2019, suggesting one vaccine would be sufficient to combat global infections.

article thumbnail

Recurrent GBM brain tumors with few mutations respond best to immunotherapy

Scienmag

The finding from a genetic analysis of tumors treated with Duke’s poliovirus therapy suggests a predictive biomarker for survival DURHAM, N.C. – Glioblastoma brain tumors are especially perplexing.